IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transfer
Open Access
- 20 September 2010
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 91 (1), 54-62
- https://doi.org/10.1038/labinvest.2010.164
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt functionNature, 2008
- Salivary gland tissue expression of interleukin‐23 and interleukin‐17 in Sjögren's syndrome: Findings in humans and miceArthritis & Rheumatism, 2008
- Evaluation of Promoters for Use in Tissue-Specific Gene DeliveryPublished by Springer Science and Business Media LLC ,2008
- Interleukin-23 drives innate and T cell–mediated intestinal inflammationThe Journal of Experimental Medicine, 2006
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- Role of complement and B lymphocytes in Sjögren's syndrome-like autoimmune exocrinopathy of NOD.B10-H2b miceMolecular Immunology, 2006
- Local Adeno-Associated Virus-Mediated Interleukin 10 Gene Transfer Has Disease-Modifying Effects in a Murine Model of Sjögren's SyndromeHuman Gene Therapy, 2003
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003
- Evidence for antimuscarinic acetylcholine receptor antibody-mediated secretory dysfunction in NOD miceArthritis & Rheumatism, 2000
- Evidence for the Systemic Delivery of a Transgene Product from Salivary GlandsHuman Gene Therapy, 1996